相似文献
1
In vitro susceptibility studies with josamycin and erythromycin.
Antimicrob Agents Chemother. 1976 Mar;9(3):546-8. doi: 10.1128/AAC.9.3.546.
2
In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
Antimicrob Agents Chemother. 1990 Sep;34(9):1839-42. doi: 10.1128/AAC.34.9.1839.
3
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Antimicrob Agents Chemother. 1976 Jul;10(1):188-90. doi: 10.1128/AAC.10.1.188.
4
[Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Jpn J Antibiot. 1988 Jul;41(7):841-53.
5
Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Antimicrob Agents Chemother. 1976 Oct;10(4):773-5. doi: 10.1128/AAC.10.4.773.
6
7
The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
NIPH Ann. 1986 Dec;9(2):61-3.
8
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Antimicrob Agents Chemother. 1976 Jun;9(6):988-93. doi: 10.1128/AAC.9.6.988.
9
[In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
Minerva Med. 1983 Mar 24;74(12):619-24.
10
In-vitro activity of roxithromycin against respiratory and skin pathogens.
J Antimicrob Chemother. 1987 Nov;20 Suppl B:1-5. doi: 10.1093/jac/20.suppl_b.1.
引用本文的文献
1
Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
Antimicrob Agents Chemother. 1988 Nov;32(11):1710-9. doi: 10.1128/AAC.32.11.1710.
2
Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):67-9. doi: 10.1007/BF01962178.
3
Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.
Eur J Epidemiol. 1989 Jun;5(2):146-53. doi: 10.1007/BF00156820.
4
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
Antimicrob Agents Chemother. 1976 Oct;10(4):736-52. doi: 10.1128/AAC.10.4.736.
5
Comparative pharmacology of josamycin and erythromycin stearate.
Antimicrob Agents Chemother. 1976 Sep;10(3):450-6. doi: 10.1128/AAC.10.3.450.
6
In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
Antimicrob Agents Chemother. 1976 Aug;10(2):253-7. doi: 10.1128/AAC.10.2.253.
7
In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Antimicrob Agents Chemother. 1976 Jul;10(1):188-90. doi: 10.1128/AAC.10.1.188.
8
Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
Antimicrob Agents Chemother. 1976 Dec;10(6):899-901. doi: 10.1128/AAC.10.6.899.
9
Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets.
J Clin Microbiol. 1979 Dec;10(6):844-9. doi: 10.1128/jcm.10.6.844-849.1979.
10
In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.
Antimicrob Agents Chemother. 1977 Mar;11(3):407-10. doi: 10.1128/AAC.11.3.407.
本文引用的文献
1
Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing.
Appl Microbiol. 1970 Jul;20(1):46-53. doi: 10.1128/am.20.1.46-53.1970.
Zotero 插件